Search Results - "Nava, Tiago"
-
1
The analysis of GSTA1 promoter genetic and functional diversity of human populations
Published in Scientific reports (03-03-2021)“…GSTA1 encodes a member of a family of enzymes that function to add glutathione to target electrophilic compounds, including carcinogens, therapeutic drugs,…”
Get full text
Journal Article -
2
Simulation-Based Optimization of Sampling Schedules for Model-Informed Precision Dosing of Once-Daily and 4-Times-Daily Busulfan in Pediatric Patients
Published in Therapeutic drug monitoring (14-06-2024)“…Therapeutic drug monitoring (TDM) is crucial in optimizing the outcomes of hematopoietic stem cell transplantation by guiding busulfan (Bu) dosing. Limited…”
Get full text
Journal Article -
3
A novel integrative multi-omics approach to unravel the genetic determinants of rare diseases with application in sinusoidal obstruction syndrome
Published in PloS one (05-04-2023)“…Genotype-phenotype analyses of rare diseases often suffer from a lack of power, due to small sample size, which makes identifying significant associations…”
Get full text
Journal Article -
4
Challenges on the diagnostic approach of inherited platelet function disorders: Is a paradigm change necessary?
Published in Platelets (Edinburgh) (17-02-2018)“…Inherited platelet function disorders (IPFD) have been assessed for more than 50 years by aggregation- and secretion-based tests. Several decision trees are…”
Get full text
Journal Article -
5
The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review
Published in International journal of molecular sciences (09-08-2019)“…Hematopoietic stem cell transplantation (HSCT) remains the only curative treatment for several malignant and non-malignant diseases at the cost of serious…”
Get full text
Journal Article -
6
Predictors for participation in DNA self-sampling of childhood cancer survivors in Switzerland
Published in BMC medical research methodology (30-10-2021)“…Abstract Background Research on germline genetic variants relies on enough eligible participants which is difficult to achieve for rare diseases such as…”
Get full text
Journal Article -
7
GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation
Published in Journal of cancer research and clinical oncology (01-01-2022)“…Purpose This study aimed to retrospectively evaluate the genetic association of null variants of glutathione S-transferases GSTM1 and GSTT1 with relapse…”
Get full text
Journal Article -
8
Correction to: GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation
Published in Journal of cancer research and clinical oncology (2022)Get full text
Journal Article -
9
Genetic susceptibility to acute graft versus host disease in pediatric patients undergoing HSCT
Published in Bone marrow transplantation (Basingstoke) (01-11-2021)“…The most frequent complication of allogeneic hematopoietic stem cell transplantation is acute Graft versus Host Disease (aGVHD). Proliferation and…”
Get full text
Journal Article -
10
Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocol
Published in BMJ open (24-01-2022)“…IntroductionChildhood cancer and its treatment may lead to various health complications. Related impairment in quality of life, excess in deaths and…”
Get full text
Journal Article -
11
ABO incompatibile graft management in pediatric transplantation
Published in Bone marrow transplantation (Basingstoke) (01-01-2021)“…Up to 40% of donor-recipient pairs in SCT have some degree of ABO incompatibility, which may cause severe complications. The aim of this study was to describe…”
Get full text
Journal Article -
12
Correction: ABO incompatibile graft management in pediatric transplantation
Published in Bone marrow transplantation (Basingstoke) (2021)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
13
Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study
Published in CPT: pharmacometrics and systems pharmacology (01-09-2021)“…Busulfan (Bu) is a common component of conditioning regimens before hematopoietic stem cell transplantation (HSCT) and is known for high interpatient…”
Get full text
Journal Article -
14
Correction: Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Published in Bone marrow transplantation (Basingstoke) (01-06-2020)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
15
A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation
Published in BMC cell biology (21-01-2022)“…Sinusoidal occlusion syndrome (SOS) is a potentially severe complication following hematopoietic stem cell transplantation (HSCT) in pediatric patients…”
Get full text
Journal Article -
16
-
17
-
18
Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
Published in Bone marrow transplantation (Basingstoke) (01-07-2023)“…Busulfan (Bu) combined with cyclophosphamide (Cy) is commonly used as a myeloablative conditioning regimen for allogeneic hematopoietic cell transplantation…”
Get full text
Journal Article -
19
Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party
Published in Bone marrow transplantation (Basingstoke) (01-06-2020)“…Hematopoietic stem cell transplantation (HSCT) is currently the standard of care for many malignant and nonmalignant blood diseases. As several…”
Get full text
Journal Article -
20
Correction: Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party
Published in Bone marrow transplantation (Basingstoke) (01-06-2020)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article